Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EU committee recommends AstraZeneca’s Lynparza for breast cancer

pharmaceutical-technologyMarch 05, 2019

Tag: EU committee , AstraZeneca , Breast Cancer

PharmaSources Customer Service